Jefferies Initiates Coverage On Artivion with Buy Rating, Announces Price Target of $31
10/20/2026
Impact: 80
Healthcare
Jefferies analyst Michael Sarcone has initiated coverage on Artivion (NYSE: AORT) with a Buy rating. The firm has set a price target of $31 for the company's stock.
AI summary, not financial advice
Share: